2019 CYIR Finalized
29 Asthma Outcomes Jevnikar Z, Ostling J, Ax E, Calven J, Thorn K, Israelsson E, Oberg L, Singhania A, Lau LCK, Wilson SJ, Ward JA, Chauhan A, Sousa AR, De Meulder B, Loza MJ, Baribaud F, Sterk PJ, Chung KF, Sun K, Guo Y, Adcock IM, Payne D, Dahlen B, Chanez P, Shaw DE, Krug N, Hohlfeld JM, Sandstrom T, Djukanovic R, James A, Hinks TSC, Howarth PH, Vaarala O, van Geest M, Olsson H, Unbiased Biomarkers in Prediction of Respiratory Disease Outcomes study g. Epithelial IL-6 trans- signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2019;143(2):577-90. Brinkman P, Wagener AH, Hekking PP, Bansal AT, Maitland- van der Zee AH, Wang Y, Weda H, Knobel HH, Vink TJ, Rattray NJ, D’Amico A, Pennazza G, Santonico M, Lefaudeux D, De Meulder B, Auffray C, Bakke PS, Caruso M, Chanez P, Chung KF, Corfield J, Dahlen SE, Djukanovic R, Geiser T, Horvath I, Krug N, Musial J, Sun K, Riley JH, Shaw DE, Sandstrom T, Sousa AR, Montuschi P, Fowler SJ, Sterk PJ, Group UBS. Identification and prospective sta- bility of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma. J Allergy Clin Immunol. 2018. FitzGerald JM, Bleecker ER, Menzies-Gow A, Zangrilli JG, Hirsch I, Metcalfe P, Newbold P, Goldman M. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. Lancet Respir Med. 2018;6(1):51-64. Bennett GH, Carpenter L, Hao W, Song P, Steinberg J, Baptist AP. Risk factors and clinical outcomes associ- ated with fixed airflow obstruction in older adults with asthma. Ann Allergy Asthma Immunol. 2018;120(2):164-8 e1. Sorkness RL, Zoratti EM, Kattan M, Gergen PJ, Evans MD, Visness CM, Gill M, Khurana Hershey GK, Kercsmar CM, Liu AH, O’Connor GT, Pongracic JA, Pillai D, Sorkness CA, Togias A, Wood RA, Busse WW. Obstruction phenotype as a predictor of asthma severity and instability in chil- dren. J Allergy Clin Immunol. 2018;142(4):1090-9 e4. Langton D, Ing A, Bennetts K, Wang W, Farah C, Peters M, et al. Bronchial thermoplasty reduces gas trapping in severe asthma. BMC Pulm Med. 2018;18(1):155. Imaging Modalities and Phenotypes Increase Understanding of Asthma Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, Raymond WW, Lachowicz-Scroggins ME, Di Maio S, Hoffman EA, Castro M, Fain SB, Jarjour NN, Israel E, Levy BD, Erzurum SC, Wenzel SE, Meyers DA, Bleecker ER, Phillips BR, Mauger DT, Gordon ED, Woodruff PG, Peters MC, Fahy JV, National Heart L, Blood Institute Severe Asthma Research P. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest. 2018;128(3):997-1009. Ash SY, Rahaghi FN, Come CE, Ross JC, Colon AG, Cardet-Guisasola JC, Dunican EM, Bleecker ER, Castro M, Fahy JV, Fain SB, Gaston BM, Hoffman EA, Jarjour NN, Mauger DT, Wenzel SE, Levy BD, San Jose Estepar R, Israel E, Washko GR, SARP Investigators. Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort. Am J Respir Crit Care Med. 2018;198(1):39-50. Konietzke P, Weinheimer O, Wielputz MO, Wagner WL, Kaukel P, Eberhardt R, Heussel CP, Kauczor HU, Herth FJ, Schuhmann M. Quantitative CT detects changes in air- way dimensions and air-trapping after bronchial ther- moplasty for severe asthma. Eur J Radiol. 2018;107:33-8. Mummy DG, Kruger SJ, Zha W, Sorkness RL, Jarjour NN, Schiebler ML, Denlinger LC, Evans MD, Fain SB. Ventilation defect percent in helium-3 magnetic reso- nance imaging as a biomarker of severe outcomes in asthma. J Allergy Clin Immunol. 2018;141(3):1140-1 e4. Impact of Targeted Therapy on Characteristics of Asthma Exacerbations Shrimanker R, Pavord ID, Yancey S, Heaney LG, Green RH, Bradding P, Hargadon B, Brightling CE, Wardlaw AJ, Haldar P. Exacerbations of severe asthma in patients treated with mepolizumab. Eur Respir J. 2018;52(6). New Therapeutic Approaches to Asthma Bateman ED, O’Brien C, Rugman P, Luke S, Ivanov S, Uddin M. Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting beta2-agonists in patients with atopic asthma. Drug Des Devel Ther. 2018;12:1093-106. ASTHMA
Made with FlippingBook
RkJQdWJsaXNoZXIy MTM1ODMw